These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36226626)

  • 1. High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome.
    da Silva LMB; Borges IBP; Shinjo SK
    Clin Exp Rheumatol; 2023 Mar; 41(2):238-246. PubMed ID: 36226626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antisynthetase myopathy].
    Suzuki S
    Rinsho Shinkeigaku; 2020 Mar; 60(3):175-180. PubMed ID: 32101845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.
    Mozaffar T; Pestronk A
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):472-8. PubMed ID: 10727483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the sensitivity and specificity of MHC-I and MHC-II immunohistochemical staining in muscle biopsies for the diagnosis of inflammatory myopathies.
    Rodríguez Cruz PM; Luo YB; Miller J; Junckerstorff RC; Mastaglia FL; Fabian V
    Neuromuscul Disord; 2014 Dec; 24(12):1025-35. PubMed ID: 25153265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJL; Franceschini F; Neri R; Castañeda S; Giraldo WAS; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Murcia TP; La Corte R; Furini F; Foschi V; Corral JB; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Montecucco C; González-Gay MA;
    Medicine (Baltimore); 2015 Aug; 94(32):e1144. PubMed ID: 26266346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
    Kryštůfková O; Barbasso Helmers S; Venalis P; Malmström V; Lindroos E; Vencovský J; Lundberg IE
    Arthritis Res Ther; 2014 Oct; 16(5):454. PubMed ID: 25301447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Necrotising myopathy, an unusual presentation of a steroid-responsive myopathy.
    Bronner IM; Hoogendijk JE; Wintzen AR; van der Meulen MF; Linssen WH; Wokke JH; de Visser M
    J Neurol; 2003 Apr; 250(4):480-5. PubMed ID: 12700915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
    Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
    J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.
    Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H
    Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
    Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Necrotizing Myopathy and Fibrinous and Organizing Pneumonia with Anti-EJ Antisynthetase Syndrome and SSA Antibodies.
    Kashif M; Arya D; Niazi M; Khaja M
    Am J Case Rep; 2017 Apr; 18():448-453. PubMed ID: 28439062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
    BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group.
    Cavagna L; Nuño L; Scirè CA; Govoni M; Longo FJ; Franceschini F; Neri R; Castañeda S; Sifuentes Giraldo WA; Caporali R; Iannone F; Fusaro E; Paolazzi G; Pellerito R; Schwarting A; Saketkoo LA; Ortego-Centeno N; Quartuccio L; Bartoloni E; Specker C; Pina Murcia T; La Corte R; Furini F; Foschi V; Bachiller Corral J; Airò P; Cavazzana I; Martínez-Barrio J; Hinojosa M; Giannini M; Barsotti S; Menke J; Triantafyllias K; Vitetta R; Russo A; Bogliolo L; Bajocchi G; Bravi E; Barausse G; Bortolotti R; Selmi C; Parisi S; Salaffi F; Montecucco C; González-Gay MA;
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):71-80. PubMed ID: 26782036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy.
    Acosta IJ; Hofer M; Brady S
    Neuromuscul Disord; 2022 May; 32(5):441-444. PubMed ID: 35487868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle pathology of antisynthetase syndrome according to antibody subtypes.
    Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Suzuki S; Nishino I
    Brain Pathol; 2023 Jul; 33(4):e13155. PubMed ID: 36882048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
    Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
    Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.